4. Fcpr Biodiscovery serves as Executive at Axonics Modulation Technologies, Inc., where they oversee executive responsibilities. Since joining the company, 4. Fcpr Biodiscovery has executed 3 insider transactions totaling $15.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 22, 2020 involved selling 135,261 shares valued at $4.3M.
4. Fcpr Biodiscovery currently holds 2,957,461 shares of Axonics Modulation Technologies, Inc. (AXNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, 4. Fcpr Biodiscovery has been a net seller of AXNX stock. They have purchased $0 and sold $15.7M worth of shares.
4. Fcpr Biodiscovery's most recent insider trade was on Jan 22, 2020, when they sold 135,261 shares at $31.54 per share.
Get notified when new Form 4 filings are submitted
| $31.51 |
| Discretionary |
| Nov 22, 2019 | AXNX | $6.2M | Sale | 300,000 | $20.74 | Discretionary |